March 7, 2025 07:00 AM ESTUpdated 09:30 AM
Peer Review

Tune’s CEO search ends as John McHutchi­son takes top spot; More from Pfiz­er’s lead­er­ship makeover

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Lei Lei Wu

News Reporter

John McHutchi­son start­ed Mon­day as CEO and chair­man of Tune Ther­a­peu­tics, af­ter sit­ting on the com­pa­ny’s board for two years. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

TRENDING NOW

Stock mar­ket melts down over Trump’s tar­iffs, and biotech's pain keeps grow­ing

‘This is self-in­flict­ed’: Leerink’s David Risinger on the mar­ket shock and hits to bio­phar­ma

Rare dis­ease hub at CDER and CBER faces new re­al­i­ty with staff crunch

RFK Jr. won’t tes­ti­fy be­fore key Sen­ate com­mit­tee this week on HHS over­haul

HHS says it may re­vis­it an­ti-obe­si­ty drug poli­cies af­ter drop­ping Biden-era pro­pos­al

GSK’s newest neu­ro pact is with ABL Bio, a Sanofi-part­nered South Ko­re­an biotech

A service from the Financial Times